Gemeinschaftspraxis Dres Haggenmiller/Jeserich

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Familial hypercholesterolaemia

Closed trials

• Completed

  Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of life, when given along with other lipid lowering medications.

  2024-511263-28-00· Phase 4· Novartis Pharma AG· Source